Manufacturing Services

Filling Small Batches

May 16, 2021

Advances in automation and cleanroom technology improve efficiency for small commercial quantities of aseptically filled drug products.

Breaking the Cold Chain for Vaccines

May 16, 2021

Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines.

Wavelength Pharmaceuticals Acquires Vanamali Organics

February 18, 2021

The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.

Will Advanced Technology Redefine Bio/Pharma's Agility?

February 09, 2021

Model-based approaches and digital analytics are improving flexibility at both the equipment and the manufacturing-line level.

Meeting Fill/Finish Challenges for COVID-19 Vaccines

February 02, 2021

CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.

Sygnature Discovery Expands High-Throughput Screening and Translational Oncology

December 23, 2020

The UK company is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening and translational oncology service offerings.

Cytiva Expands Cell and Gene Therapy Fast Trak Services

December 09, 2020

Cytiva is adding process development, media and assay development, and contract development services at its facilities in Korea, Japan, Sweden, and the UK.

Piramal Expands API Capacity in Michigan

December 09, 2020

Piramal Pharma Solutions invests in expanded potent and non-potent API development and manufacturing at its Riverview, MI facility.

Manufacturing Materials for Clinical Trials

December 02, 2020

CDMOs strive for flexible, adaptable processes and fast tech transfer for manufacturing investigational drug products, including COVID-19 treatments and vaccines.

Industry Builds Fill/Finish Capacity for Pandemic Response

July 15, 2020

Equipment and Processing Report

Filling and packaging of primary containers is a crucial piece of COVID-19 vaccine and therapeutic production.